chr12-6333879-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001065.4(TNFRSF1A):c.194-14G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,601,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )
Consequence
TNFRSF1A
NM_001065.4 intron
NM_001065.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.84
Genes affected
TNFRSF1A (HGNC:11916): (TNF receptor superfamily member 1A) This gene encodes a member of the TNF receptor superfamily of proteins. The encoded receptor is found in membrane-bound and soluble forms that interact with membrane-bound and soluble forms, respectively, of its ligand, tumor necrosis factor alpha. Binding of membrane-bound tumor necrosis factor alpha to the membrane-bound receptor induces receptor trimerization and activation, which plays a role in cell survival, apoptosis, and inflammation. Proteolytic processing of the encoded receptor results in release of the soluble form of the receptor, which can interact with free tumor necrosis factor alpha to inhibit inflammation. Mutations in this gene underlie tumor necrosis factor receptor-associated periodic syndrome (TRAPS), characterized by fever, abdominal pain and other features. Mutations in this gene may also be associated with multiple sclerosis in human patients. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 22 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFRSF1A | NM_001065.4 | c.194-14G>A | intron_variant | ENST00000162749.7 | NP_001056.1 | |||
TNFRSF1A | NM_001346091.2 | c.-131-14G>A | intron_variant | NP_001333020.1 | ||||
TNFRSF1A | NM_001346092.2 | c.-384-14G>A | intron_variant | NP_001333021.1 | ||||
TNFRSF1A | NR_144351.2 | n.456-14G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFRSF1A | ENST00000162749.7 | c.194-14G>A | intron_variant | 1 | NM_001065.4 | ENSP00000162749.2 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152142Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
22
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000142 AC: 32AN: 225480Hom.: 0 AF XY: 0.000123 AC XY: 15AN XY: 121700
GnomAD3 exomes
AF:
AC:
32
AN:
225480
Hom.:
AF XY:
AC XY:
15
AN XY:
121700
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000184 AC: 266AN: 1449276Hom.: 0 Cov.: 33 AF XY: 0.000178 AC XY: 128AN XY: 719910
GnomAD4 exome
AF:
AC:
266
AN:
1449276
Hom.:
Cov.:
33
AF XY:
AC XY:
128
AN XY:
719910
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000145 AC: 22AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74324
GnomAD4 genome
AF:
AC:
22
AN:
152142
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74324
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2022 | TNFRSF1A: PS4:Moderate, PM4:Supporting, PS3:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 30, 2021 | Published previously in association with TRAPS; however, the variant was also observed in unaffected family members and in an individual who had a remittance of symptoms (Aksentijevich et al., 2001; D'Osualdo et al., 2006; Stojanov et al., 2008; Gattorno et al., 2008); Functional studies have shown this variant creates a cryptic splice acceptor site, resulting in an insertion of four additional amino acids (Aksentijevich et al., 2001); Reported previously using alternate nomenclature (c.193-14 G>A); This variant is associated with the following publications: (PMID: 12352631, 16508982, 25525159, 15228182, 19541728, 12209523, 18180277, 19877056, 13130484, 33181346, 11443543, 18512793, 28166811) - |
TNF receptor-associated periodic fever syndrome (TRAPS) Uncertain:1Other:1
not provided, no classification provided | literature only | Unité médicale des maladies autoinflammatoires, CHRU Montpellier | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | This sequence change falls in intron 2 of the TNFRSF1A gene. It does not directly change the encoded amino acid sequence of the TNFRSF1A protein. RNA analysis indicates that this variant induces altered splicing and likely results in the gain of 4 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is present in population databases (rs104895241, gnomAD 0.03%). This variant has been observed in individual(s) with tumor necrosis factor receptor–associated periodic syndrome (PMID: 11443543, 18180277). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 97654). Studies have shown that this variant results in the activation of a cryptic splice site in intron 3 (PMID: 11443543). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
TNFRSF1A-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 03, 2024 | The TNFRSF1A c.194-14G>A variant is predicted to interfere with splicing. This variant is predicted to interfere with normal spicing by activating a cryptic splice acceptor (SpliceAI, Jaganathan K, et al. 2019. PubMed ID: 30661751). In vitro functional analyses supported this prediction, indicating that aberrant splicing results in the addition of four amino acids (variant described as c.193-14G>A, Aksentijevich et al 2001. PubMed ID: 11443543). This variant was reported in five patients from two families with TNF receptor-associated periodic syndrome (TRAPS) (Aksentijevich et al 2001. PubMed ID: 11443543). It is reported in 0.027% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect this variant may be pathogenic, at this time the clinical significance is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at